上海肝病在线 Shanghai Liver Diseases' Online

Phenotypic Flow Cytometry Measurment of LAK（+APC）cells IN Vitro

CD4+/CD8+/TCRγδ+Three Colour Method：CD4-CD8-CDTCRγδ-（11.2%），CD4-CD8+CDTCRγδ-（48.7%，anti-tumor and antiviral CTL），CD4+-CD8-CDTCRγδ-（2.8%），CD4+CD8+CDTCRγδ-（9.3%），CD4-CD8-CDTCRγδ+（3.5%），CD4-CD8+CDTCRγδ+（8.2%），CD4+CD8-CDTCRγδ+（13.5%），CD4+CD8+CDTCRγδ+（2.9%）。

CD3+/CD56+/CD57+Three Colour Method：CD3-CD56-CD57-（0.7%），CD3-CD56-CD57+（0.3%），CD3-CD56+CD57-（0.6%），CD3-CD56+CD57+（0.5%），CD3+CD56-CD57-（57.7%），CD3+CD56-CD57+（17.9%，immunoregulatory NK-T cells），CD3+CD56+CD57-（18.6%，immunostimulatory NK-T cells,anti-tumor and antiviral activity），CD3+CD56+CD57+（4.0%）;

LAK（+APC）CD4/CD8/TCR gamma delta three-colour Flow cytometry Measurement(Fig 1) LAK（+APC）CD4/CD8/TCR gamma delta three-colour Flow cytometry Measurement(Fig 2) LAK（+APC）CD3/CD56/CD57three-colour Flow cytometry Measurement(Fig 1) LAK（+APC）CD3/CD56/CD57three-colour Flow cytometry Measurement(Fig 2)
An Other patient PBMC CD4/CD8/TCR gamma delta three-colour Flow cytometry Measurement(Fig 1) An other patient PBMC CD4/CD8/TCR gamma delta three-colour Flow cytometry Measurement(Fig 2) An other patient PBMC CD3/CD56/CD57three-colour Flow cytometry Measurement(Fig 1) An other patient PBMC CD3/CD56/CD57three-colour Flow cytometry Measurement(Fig 2)